Camp4 Therapeutics CORP (CAMP) — Institutional Investor Activity (Q2 2026)

CAMP ranks #5624 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

CAMP is a top-conviction position for 5AM Venture Management, LLC — at 8.9% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in CAMP belongs to Jupiter Topco LLC, but the position matters far more to 5AM Venture Management, LLC, who has 8.9% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

State Street has added to its CAMP position for two straight quarters, increasing it by $1.3M to reach $1.6M today.

Enavate Sciences GP, LLC has trimmed its CAMP position for two straight quarters, cutting it by $12.4M while still holding $6.2M.

CAMP is up 0.3% today, and institutions have been net buyers of $11.1M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

CAMP reported a net loss of $107.2M over the trailing twelve months.

• Not yet profitable — net loss of $107.2M over the trailing twelve months
• Revenue grew 100.7% year over year
• Net income declined year over year, from -$51.8M to -$107.2M
• Operating cash flow was negative, using $29.6M in cash
• Current ratio of 7.35x — enough short-term assets to cover short-term liabilities
• Liabilities run 1.47x equity — within a conventional range